Search details
1.
Efficacy and safety of CD34-selected and CD19-depleted autografting in multiple myeloma patients: a pilot study.
Exp Hematol
; 30(1): 82-8, 2002 Jan.
Article
in English
| MEDLINE | ID: mdl-11823041
2.
Circulating tumor necrosis factor-α and YKL-40 level is associated with remission status following salvage therapy in relapsed non-Hodgkin lymphoma.
Leuk Lymphoma
; 56(8): 2476-8, 2015.
Article
in English
| MEDLINE | ID: mdl-25563560
3.
[Stem cell harvesting after plerixafor treatment]. / Stamcellehøst efter behandling med plerixafor.
Ugeskr Laeger
; 171(47): 3452-3, 2009 Nov 16.
Article
in Danish
| MEDLINE | ID: mdl-19925734
4.
[Mobilisation of haematopoietic stem cells with plerixafor--secondary publication]. / Mobilisering af haematopoietiske stamceller med plerixafor--sekundaerpublikation.
Ugeskr Laeger
; 171(45): 3272-5, 2009 Nov 02.
Article
in Danish
| MEDLINE | ID: mdl-19887056
5.
Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.
Cancer Immunol Immunother
; 56(9): 1485-99, 2007 Sep.
Article
in English
| MEDLINE | ID: mdl-17285289
6.
Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study.
Cancer Immunol Immunother
; 53(7): 633-41, 2004 Jul.
Article
in English
| MEDLINE | ID: mdl-14985857
Results
1 -
6
de 6
1
Next >
>>